478 related articles for article (PubMed ID: 29696341)
1. Risk stratification in hypertrophic cardiomyopathy.
Marrakchi S; Kammoun I; Bennour E; Laroussi L; Kachboura S
Herz; 2020 Feb; 45(1):50-64. PubMed ID: 29696341
[TBL] [Abstract][Full Text] [Related]
2. Prevention of sudden death in hypertrophic cardiomyopathy: bridging the gaps in knowledge.
Weissler-Snir A; Adler A; Williams L; Gruner C; Rakowski H
Eur Heart J; 2017 Jun; 38(22):1728-1737. PubMed ID: 27371714
[TBL] [Abstract][Full Text] [Related]
3. Sudden death related cardiomyopathies - Hypertrophic cardiomyopathy.
Goff ZD; Calkins H
Prog Cardiovasc Dis; 2019; 62(3):212-216. PubMed ID: 31004609
[TBL] [Abstract][Full Text] [Related]
4. Worldwide differences in primary prevention implantable cardioverter defibrillator utilization and outcomes in hypertrophic cardiomyopathy.
Nauffal V; Marstrand P; Han L; Parikh VN; Helms AS; Ingles J; Jacoby D; Lakdawala NK; Kapur S; Michels M; Owens AT; Ashley EA; Pereira AC; Rossano JW; Saberi S; Semsarian C; Ware JS; Wittekind SG; Day S; Olivotto I; Ho CY
Eur Heart J; 2021 Oct; 42(38):3932-3944. PubMed ID: 34491319
[TBL] [Abstract][Full Text] [Related]
5. The amount of late gadolinium enhancement outperforms current guideline-recommended criteria in the identification of patients with hypertrophic cardiomyopathy at risk of sudden cardiac death.
Freitas P; Ferreira AM; Arteaga-Fernández E; de Oliveira Antunes M; Mesquita J; Abecasis J; Marques H; Saraiva C; Matos DN; Rodrigues R; Cardim N; Mady C; Rochitte CE
J Cardiovasc Magn Reson; 2019 Aug; 21(1):50. PubMed ID: 31412875
[TBL] [Abstract][Full Text] [Related]
6. Validation of the 2014 European Society of Cardiology guidelines risk prediction model for the primary prevention of sudden cardiac death in hypertrophic cardiomyopathy.
Vriesendorp PA; Schinkel AF; Liebregts M; Theuns DA; van Cleemput J; Ten Cate FJ; Willems R; Michels M
Circ Arrhythm Electrophysiol; 2015 Aug; 8(4):829-35. PubMed ID: 25922410
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the new risk prediction model (HCM Risk-SCD) and classic risk factors for sudden death in patients with hypertrophic cardiomyopathy and defibrillator.
Ruiz-Salas A; García-Pinilla JM; Cabrera-Bueno F; Fernández-Pastor J; Peña-Hernández J; Medina-Palomo C; Barrera-Cordero A; De Teresa E; Alzueta J
Europace; 2016 May; 18(5):773-7. PubMed ID: 25855675
[TBL] [Abstract][Full Text] [Related]
8. Predicting therapies in Japanese hypertrophic cardiomyopathy patients with an implantable cardioverter-defibrillator using the 2014 European Society of Cardiology guidelines.
Nakano M; Kondo Y; Nakano M; Kajiyama T; Miyazawa K; Hayashi T; Ito R; Takahira H; Kobayashi Y
Heart Vessels; 2021 Jan; 36(1):99-104. PubMed ID: 32666207
[TBL] [Abstract][Full Text] [Related]
9. ESC sudden-death risk model in hypertrophic cardiomyopathy: Incremental value of quantitative contrast-enhanced CMR in intermediate-risk patients.
Hinojar R; Zamorano JL; Gonzalez Gómez A; Plaza Martin M; Esteban A; Rincón LM; Portugal JC; Jimenez Nácher JJ; Fernández-Golfín C
Clin Cardiol; 2017 Oct; 40(10):853-860. PubMed ID: 28614597
[TBL] [Abstract][Full Text] [Related]
10. Implantable cardioverter defibrillator therapy and sudden death risk stratification in hypertrophic cardiomyopathy patients with midventricular obstruction: A single-center experience.
Maeda R; Minami Y; Haruki S; Kanbayashi K; Itani R; Suzuki A; Ejima K; Shiga T; Shoda M; Hagiwara N
Int J Cardiol; 2016 Jul; 214():419-22. PubMed ID: 27088403
[TBL] [Abstract][Full Text] [Related]
11. Updated risk assessments for sudden cardiac death in hypertrophic cardiomyopathy patients with implantable cardioverter-defibrillator.
Park YM
Korean J Intern Med; 2023 Jan; 38(1):7-15. PubMed ID: 36353786
[TBL] [Abstract][Full Text] [Related]
12. Recommendations of the current guidelines for implantable cardioverter-defibrillator implantation in patients with hypertrophic cardiomyopathy: Debate still exists.
Aminorroaya A; Vasheghani-Farahani A; Masoudkabir F; Roayaei P
J Interv Card Electrophysiol; 2021 Jan; 60(1):1-7. PubMed ID: 32712900
[TBL] [Abstract][Full Text] [Related]
13. Temporal and Global Trends of the Incidence of Sudden Cardiac Death in Hypertrophic Cardiomyopathy.
Abdelfattah OM; Martinez M; Sayed A; ElRefaei M; Abushouk AI; Hassan A; Masri A; Winters SL; Kapadia SR; Maron BJ; Rowin E; Maron MS
JACC Clin Electrophysiol; 2022 Nov; 8(11):1417-1427. PubMed ID: 36424010
[TBL] [Abstract][Full Text] [Related]
14. Hypertrophic Cardiomyopathy-Related Sudden Cardiac Death in Young People in Ontario.
Weissler-Snir A; Allan K; Cunningham K; Connelly KA; Lee DS; Spears DA; Rakowski H; Dorian P
Circulation; 2019 Nov; 140(21):1706-1716. PubMed ID: 31630535
[TBL] [Abstract][Full Text] [Related]
15. Risk stratification and role of implantable defibrillators for prevention of sudden death in patients with hypertrophic cardiomyopathy.
Maron BJ
Circ J; 2010 Nov; 74(11):2271-82. PubMed ID: 20962423
[TBL] [Abstract][Full Text] [Related]
16. Evolution of risk stratification and sudden death prevention in hypertrophic cardiomyopathy: Twenty years with the implantable cardioverter-defibrillator.
Maron BJ; Rowin EJ; Maron MS
Heart Rhythm; 2021 Jun; 18(6):1012-1023. PubMed ID: 33508516
[TBL] [Abstract][Full Text] [Related]
17. Current perspectives of sudden cardiac death management in hypertrophic cardiomyopathy.
Pu L; Li J; Qi W; Zhang J; Chen H; Tang Z; Han Y; Wang J; Chen Y
Heart Fail Rev; 2024 Mar; 29(2):395-404. PubMed ID: 37865929
[TBL] [Abstract][Full Text] [Related]
18. Implantable cardioverter defibrillators for primary prevention of sudden death in hypertrophic cardiomyopathy.
Konstantinou DM; Efthimiadis GK; Vassilikos V; Paraskevaidis S; Pagourelias E; Maron BJ; Karvounis H
J Cardiovasc Med (Hagerstown); 2016 Jun; 17(6):433-9. PubMed ID: 26885981
[TBL] [Abstract][Full Text] [Related]
19. The Risk of Sudden Death in Children with Hypertrophic Cardiomyopathy.
Norrish G; Kaski JP
Heart Fail Clin; 2022 Jan; 18(1):9-18. PubMed ID: 34776087
[TBL] [Abstract][Full Text] [Related]
20. Contemporary strategies for risk stratification and prevention of sudden death with the implantable defibrillator in hypertrophic cardiomyopathy.
Maron BJ; Maron MS
Heart Rhythm; 2016 May; 13(5):1155-1165. PubMed ID: 26749314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
